18.10
Schlusskurs vom Vortag:
$18.25
Offen:
$18.19
24-Stunden-Volumen:
5.59M
Relative Volume:
0.89
Marktkapitalisierung:
$17.30B
Einnahmen:
$10.69B
Nettoeinkommen (Verlust:
$-156.47M
KGV:
-109.37
EPS:
-0.1655
Netto-Cashflow:
$-3.55B
1W Leistung:
+3.90%
1M Leistung:
-5.53%
6M Leistung:
-14.62%
1J Leistung:
-0.66%
Xpeng Inc Adr Stock (XPEV) Company Profile
Firmenname
Xpeng Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare XPEV vs TSLA, TM, GM, RACE, F
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
XPEV
Xpeng Inc Adr
|
18.10 | 17.30B | 10.69B | -156.47M | -3.55B | -0.1655 |
|
TSLA
Tesla Inc
|
400.62 | 1.50T | 94.83B | 3.86B | 6.22B | 1.076 |
|
TM
Toyota Motor Corporation Adr
|
217.20 | 283.09B | 337.18B | 25.73B | 300.48M | 18.92 |
|
GM
General Motors Company
|
81.32 | 73.51B | 185.02B | 2.78B | 1.77B | 3.0106 |
|
RACE
Ferrari N V
|
372.85 | 65.78B | 8.07B | 1.81B | 1.64B | 10.10 |
|
F
Ford Motor Co
|
12.87 | 51.62B | 187.27B | -8.16B | 12.47B | -1.9158 |
Xpeng Inc Adr Stock (XPEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-23 | Herabstufung | Macquarie | Outperform → Neutral |
| 2025-11-18 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2025-08-18 | Eingeleitet | BNP Paribas Exane | Neutral |
| 2025-06-17 | Hochstufung | Goldman | Neutral → Buy |
| 2025-05-21 | Hochstufung | Macquarie | Neutral → Outperform |
| 2025-03-19 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2025-03-19 | Hochstufung | Nomura | Neutral → Buy |
| 2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-02-24 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-07 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-12-05 | Herabstufung | UBS | Neutral → Sell |
| 2024-11-22 | Hochstufung | China Renaissance | Hold → Buy |
| 2024-11-21 | Herabstufung | Goldman | Buy → Neutral |
| 2024-09-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-08-30 | Hochstufung | Macquarie | Neutral → Outperform |
| 2024-06-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2024-05-23 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-04-15 | Fortgesetzt | Macquarie | Neutral |
| 2023-08-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Hochstufung | CLSA | Outperform → Buy |
| 2023-08-07 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-07-31 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-27 | Hochstufung | Macquarie | Underperform → Outperform |
| 2023-07-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-11 | Eingeleitet | Goldman | Buy |
| 2023-06-30 | Herabstufung | CLSA | Buy → Outperform |
| 2023-05-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-04-25 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-24 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-02-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-01-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-14 | Herabstufung | Daiwa Securities | Buy → Sell |
| 2022-11-28 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2022-10-28 | Herabstufung | Citigroup | Buy → Sell |
| 2022-08-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-08-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2022-07-01 | Herabstufung | Nomura | Buy → Neutral |
| 2022-05-25 | Eingeleitet | Macquarie | Outperform |
| 2022-04-01 | Eingeleitet | HSBC Securities | Buy |
| 2022-03-24 | Eingeleitet | China Renaissance | Buy |
| 2022-03-23 | Eingeleitet | CLSA | Buy |
| 2022-02-08 | Eingeleitet | Barclays | Overweight |
| 2022-01-12 | Eingeleitet | Macquarie | Outperform |
| 2021-10-28 | Eingeleitet | Bernstein | Outperform |
| 2021-05-26 | Eingeleitet | Nomura | Buy |
| 2021-03-09 | Hochstufung | Daiwa Securities | Sell → Buy |
| 2021-01-29 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-19 | Eingeleitet | Jefferies | Hold |
| 2020-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2020-12-03 | Herabstufung | UBS | Buy → Neutral |
| 2020-11-04 | Eingeleitet | Citigroup | Buy |
| 2020-09-25 | Eingeleitet | UBS | Buy |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-21 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Xpeng Inc Adr Aktie (XPEV) Neueste Nachrichten
XPeng (NYSE: XPEV) awards 2.26M RSUs to 69 employees under 2025 plan - Stock Titan
Jiaming Wu Net Worth (2026) - GuruFocus
Brian Hongdi Gu Net Worth (2026) - GuruFocus
XPENG (NYSE: XPEV) outlines 2025 ESG results, carbon cuts and 2050 targets - Stock Titan
Bank of America Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV) - The Globe and Mail
XPENG Files 2025 Annual Report on Form 20-F - The Manila Times
XPENG puts 2025 Form 20-F online, offers free hard copies - Stock Titan
XPeng (NYSE: XPEV) surges 2025 revenue but flags China and capital risks - Stock Titan
XPENG Publishes 2025 Environmental, Social and Governance Report - The Manila Times
XPENG (NYSE:XPEV) Shares Gap DownHere's Why - MarketBeat
XPeng, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Total Deliveries of XPENG-W's MONA M03 Exceed 250K Units - AASTOCKS.com
XPEV Stock Quote Price and Forecast - CNN
XPENG (XPEV) Institutional Ownership 2026 - MarketBeat
XPENG-W Conducts In-depth Co-op with Fuyao Group w/ Official Mass Production & Delivery of 1st AI Switchable Privacy Glass for GX - AASTOCKS.com
Why XPeng Shares Are Suddenly Sinking Today - TipRanks
Xpeng CEO Says He 'Can't Wait' To Get International Media To Test Company's Autonomous Driving Model - Benzinga
XPENG Inc. Sponsored ADR (NYSE:XPEV) Receives Average Rating of "Hold" from Brokerages - MarketBeat
NIO, XPeng & Li Auto Report Delivery Result for March & Q1 - TradingView — Track All Markets
XPeng Earnings Call: Profit Breakthrough and AI Gambit - TipRanks
XPeng Inc stock: President's big share vesting — what it signals now - AD HOC NEWS
XPENG (XPEV) president gains 600,000 shares from RSU vesting - Stock Titan
FRA:8XPA PB Ratio: 3.86 — Near Median - GuruFocus
XPEV News | XPENG INCADR (NYSE:XPEV) - ChartMill
XPeng (XPEV) downgraded by two firms - MSN
XPENG (NYSE: XPEV) surges March deliveries and outlines Latin America growth plan - Stock Titan
XPeng Boosts Deliveries and Sets Aggressive Growth Strategy in Latin America - TipRanks
Bernstein raises its price target on XPeng (XPEV) to $22 - MSN
XPENG Announces Vehicle Delivery Results for March and First Quarter 2026 - The Manila Times
XPENG-W's Deliveries Reach 27,400 Vehicles in Mar, Up 80% MoM - AASTOCKS.com
NASDAQ down over 1%; XPeng shares fall after Q4 results - MSN
XPeng (XPEV) is considered a good investment by brokers: Is that true? - MSN
2026 Xpeng MONA M03 to Be Launched on Thu w/ Expected Guide Price Range Kept at RMB119,800-RMB139,800 - AASTOCKS.com
XPeng (NYSE: XPEV) changes Chinese name and Hong Kong stock short name - Stock Titan
SG Americas Securities LLC Has $23.70 Million Holdings in XPENG Inc. Sponsored ADR $XPEV - MarketBeat
XPENG-W to Change CN Stock Short Name Next Wed - AASTOCKS.com
FRA:8XP PB Ratio: 4.14 — Near Median - gurufocus.com
XPENG-W Launches 2 New Models in Mexico, Unveils 3-Yr Strategy for Latin America - AASTOCKS.com
XPENG (NYSE:XPEV) Shares Down 7.6%What's Next? - MarketBeat
Why XPeng, Inc. ADR Shares Keep Sliding - TipRanks
Jefferies Reaffirms Their Buy Rating on XPeng, Inc. ADR (XPEV) - The Globe and Mail
XPeng, Inc. Class A (9868) Receives a Buy from Huatai Securities - The Globe and Mail
China Merchants Securities Reaffirms Their Buy Rating on XPeng, Inc. Class A (9868) - The Globe and Mail
Analysts Offer Insights on Consumer Cyclical Companies: XPeng, Inc. ADR (XPEV), KB Home (KBH) and Carnival (CCL) - The Globe and Mail
Barclays Lowers XPENG (NYSE:XPEV) Price Target to $16.00 - MarketBeat
XPeng: Looks Like A Tesla That Keeps Its Promises, Long-Term Strong Buy (NYSE:XPEV) - Seeking Alpha
Macquarie downgrades XPeng Inc.depositary receipt (XPEV) - MSN
XPENG-W Delivers 55,000th X9 MPV at BIMS - AASTOCKS.com
CICC Sticks to Their Buy Rating for XPeng, Inc. Class A (9868) - The Globe and Mail
CMSI Keeps Overweight on XPENG-W; Commercialization of New AI Biz Speeding Up - AASTOCKS.com
G Sachs: XPENG-W (09868.HK) New Model & Tech Monetization Can Offset Cost Pressure; Rating Kept at Buy w/ TP $85 - AASTOCKS.com
Finanzdaten der Xpeng Inc Adr-Aktie (XPEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):